

DESTINY-Lung02 phase 2 trial shows clinically meaningful efficacy and favorable safety at 5.4 mg/kg dose versus 6.4 mg/kg dose of Daiichi Sankyo...


Extended follow-up data from phase 1/2 trial of DS-7300 in patients with metastatic lung, prostate or esophageal cancer to be featured in...


Tislelizumab demonstrated non-inferiority for overall survival and favorable safety profile versus sorafenib in global Phase 3 trial Additional poster presentations show breadth...


HONG KONG–(BUSINESS WIRE)–#insurance—AM Best has revised the implications of the under review status to positive from developing for the Financial Strength Rating...


DUBLIN–(BUSINESS WIRE)–The “Global Healthcare Archiving Ediscovery Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The healthcare archiving eDiscovery market is poised...


DUBLIN–(BUSINESS WIRE)–The “Interior Decorative Products Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Interior Decorative Products has...


DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Healthcare Fraud Analytics Market Size, Share & Industry Trends Analysis Report By Delivery Model, By Application, By End...


DUBLIN–(BUSINESS WIRE)–The “Leadership Quadrant of Bio-Plasticizer Suppliers – 2022” report has been added to ResearchAndMarkets.com’s offering. The bio-plasticizer manufacture landscape is diverse...


DUBLIN–(BUSINESS WIRE)–The “Digital Rights Management Market – Vietnam Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Mobile Content, Video...


SEOUL, South Korea–(BUSINESS WIRE)–#AIDataService—INFINIQ, the leading AI data company in South Korea, has introduced a data anonymization solution that automatically detects and...